Clinical Trial Update: Quantitative Analysis of Myocardial Uptake of Bone Radiopharmaceuticals in Patients With Cardiac ATTR Amyloidosis [NA]

View source ↗

Summary

An ongoing clinical trial is evaluating quantitative myocardial uptake of bone radiopharmaceuticals in patients with transthyretin-related cardiac amyloidosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiac Amyloidosis
• Transthyretin Amyloidosis

Snippet

Sponsor: University Hospital, Caen | Conditions: Amyloidosis Transthyretin | NA | Status: RECRUITING